Free from Publisher

Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity

A Ardavanis, S Koumna, I Fragos, S Malliou… - Anticancer …, 2008 - ar.iiarjournals.org
Background: Treatment of non-small cell lung cancer (NSCLC) with tyrosine kinase
inhibitors (TKIs) of epidermal growth factor receptor (EGFR) and particularly erlotinib …
被引用次数：9 相关文章

Erlotinib monotherapy in patients with advanced non-small cell lung cancer: An effective approach with low toxicity

A Ardavanis, S Koumna, I Fragos… - Anticancer …, 2008 - einstein.elsevierpure.com
Background: Treatment of non-small cell lung cancer (NSCLC) with tyrosine kinase
inhibitors (TKIs) of epidermal growth factor receptor (EGFR) and particularly erlotinib …

[引用][C] Erlotinib Monotherapy in Patients with Advanced Non-small Cell Lung Cancer: An Effective Approach with Low Toxicity

A ARDAVANIS, S KOUMNA, I FRAGOS… - Anticancer …, 2008 - pascal-francis.inist.fr
Erlotinib Monotherapy in Patients with Advanced Non-small Cell Lung Cancer : An Effective
Approach with Low Toxicity CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[PDF] iiarjournals.org

[PDF][PDF] Erlotinib Monotherapy in Patients with Advanced Non-small Cell Lung Cancer: An Effective Approach with Low Toxicity

A ARDAVANIS, S KOUMNA, I FRAGOS… - ANTICANCER …, 2008 - ar.iiarjournals.org
Background: Treatment of non-small cell lung cancer (NSCLC) with tyrosine kinase
inhibitors (TKIs) of epidermal growth factor receptor (EGFR) and particularly erlotinib …

Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity

A Ardavanis, S Koumna, I Fragos… - Anticancer …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Treatment of non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors
(TKIs) of epidermal growth factor receptor (EGFR) and particularly erlotinib (Tarceva) has …
[PDF] researchgate.net

[PDF][PDF] Erlotinib Monotherapy in Patients with Advanced Non-small Cell Lung Cancer: An Effective Approach with Low Toxicity

A ARDAVANIS, S KOUMNA, I FRAGOS… - ANTICANCER …, 2008 - researchgate.net
Background: Treatment of non-small cell lung cancer (NSCLC) with tyrosine kinase
inhibitors (TKIs) of epidermal growth factor receptor (EGFR) and particularly erlotinib …

[引用][C] Erlotinib Monotherapy in Patients with Advanced Non-small Cell Lung Cancer: An Effective Approach with Low Toxicity

A ARDAVANIS, S KOUMNA… - Anticancer …, 2008 - International Institute of Anticancer …